Taysha Gene Therapies, Inc. (TSHA) Operating margin 2022–2025
Taysha Gene Therapies, Inc. (TSHA) operating margin by fiscal year — reported operating income divided by reported revenue.
-1130.6%FY2025 · since FY2022: -6492.7% → -1130.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1130.6% | -33.1 pp |
| FY2024 | -1097.6% | -628.7 pp |
| FY2023 | -468.8% | +6023.9 pp |
| FY2022 | -6492.7% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice